NovoMix 30 Flexpen to be available in Korea

Published: 2004-08-24 06:56:00

Updated: 2004-08-24 06:56:00

Novo Nordisk Korea announced on August 19 that NovoMix 30 Flexpen (reimbursable price: 11,706 won/3ml), the dual-release insulin analogue and pen system designed specifically for people starting insulin therapy, will be soon available in Korea.

NovoMix 30 Flexpen, which has been marketed in Eu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK